Predicted Trait | |
Reported Trait | Prostate cancer |
Mapped Trait(s) | prostate carcinoma (EFO_0001663) |
Score Construction | |
PGS Name | dbslmm.auto.GCST006085.Prostate_cancer |
Development Method | |
Name | DBSLMM-auto |
Parameters | auto |
Variants | |
Original Genome Build | GRCh38 |
Number of Variants | 1,139,671 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000517 |
Citation (link to publication) | Monti R et al. Am J Hum Genet (2024) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST006085 Europe PMC: 29892016 |
140,254 individuals | European | NR |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | 9,671 individuals, 100.0 % Male samples |
European | UKB | — | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM019527 | PSS011221| European Ancestry| 68,516 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | β: 0.56562 [0.52256591, 0.60866794] OR: 1.76053 [1.68634913, 1.83798146] |
AUROC: 0.6534 [0.64200647, 0.66479563] | R²: 0.07116 [0.06149625, 0.08112238] | 0 | beta = log(or)/sd_pgs |
PPM019528 | PSS011232| European Ancestry| 171,474 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.01802 [1.98114399, 2.05558361] β: 0.70212 [0.68367445, 0.7205598] |
AUROC: 0.68946 [0.68491786, 0.69400552] | R²: 0.10789 [0.10250031, 0.11315488] | 0 | beta = log(or)/sd_pgs |
PPM019529 | PSS011245| South Asian Ancestry| 19,738 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.88516 [1.54774056, 2.2961445] β: 0.63401 [0.43679617, 0.83123141] |
AUROC: 0.67831 [0.62440187, 0.7322239] | R²: 0.06162 [0.02782852, 0.10948346] | 0 | beta = log(or)/sd_pgs |
PPM019530 | PSS011261| European Ancestry| 31,410 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.83859 [1.75834334, 1.92250764] β: 0.609 [0.56437208, 0.6536304] |
AUROC: 0.66728 [0.656, 0.67855695] | R²: 0.08166 [0.07064743, 0.09305334] | 0 | beta = log(or)/sd_pgs |
PPM019531 | PSS011289| South Asian Ancestry| 4,976 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.1788 [1.80797703, 2.62568559] β: 0.77878 [0.59220855, 0.96534204] |
AUROC: 0.71889 [0.66993694, 0.76784283] | R²: 0.09456 [0.05453021, 0.14785044] | 0 | beta = log(or)/sd_pgs |
PPM019532 | PSS011274| European Ancestry| 41,305 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.93585 [1.85556023, 2.01960741] β: 0.66054 [0.61818666, 0.70290314] |
AUROC: 0.67753 [0.66663702, 0.68842668] | R²: 0.09742 [0.0854653, 0.10979243] | 0 | beta = log(or)/sd_pgs |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011274 | — | — | [ ,
100.0 % Male samples |
— | European | — | UKB | — |
PSS011245 | — | — | [ ,
100.0 % Male samples |
— | South Asian | — | G&H | — |
PSS011221 | — | — | [ ,
100.0 % Male samples |
— | European | — | EB | — |
PSS011289 | — | — | [ ,
100.0 % Male samples |
— | South Asian | — | UKB | — |
PSS011261 | — | — | [ ,
100.0 % Male samples |
— | European | — | HUNT | — |
PSS011232 | C3_PROSTATE, ICD10: C61, ICD9: 185 | — | [ ,
100.0 % Male samples |
— | European | — | FinnGen | — |